Abstract

The “trace” amines 2-phenylethylamine (PE), p-tyramine (p-TA) and tryptamine (T) have been implicated in the etiology of a number of psychiatric disorders, including depression (Dewhurst, 1968; Boulton and Milward, 1971; Sabelli and Mosnaim, 1974; Sandler et al., 1979). It is now well known that monoamine oxidase (MAO) inhibitors, drugs that are used in treatment of psychiatric disorders, cause rather dramatic increases in brain concentrations of these trace amines (Boulton et al., 1973; Axelrod and Saavedra, 1975; Philips et al., 1980; Philips and Boulton, 1979; McKim et al., 1980). However, these reports on MAO inhibitors are acute studies, and there is a paucity of information available on the effects of chronic administration of MAO inhibitors on brain levels of these compounds. In recent years, we have conducted experiments on the effects of chronic injection of two clinically efficacious MAO inhibitors, tranylcypromine (TCP) and phenelzine (PLZ) on brain levels of PE (Baker et al., 1982), p-TA (Baker et al., 1983) and T in the rat. The findings from these experiments are reviewed here.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call